Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Hamann

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Current Pharmaceutical Design|April 8, 2003
Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysisMark T Hamann
Current Pharmaceutical Design|March 10, 2007
The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural productsMark T Hamann
Current Opinion in Molecular Therapeutics|January 25, 2005
Technology evaluation: Kahalalide F, PharmaMarMark T Hamann
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistanceNoer Kasanah, Mark T Hamann
Life Sciences|October 21, 2005
Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseasesWaseem Gul, Mark T Hamann
Organic Letters|March 12, 2013
Atkamine: a new pyrroloiminoquinone scaffold from the cold water Aleutian Islands Latrunculia spongeYike Zou, Mark T Hamann
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
SPK-843 (Aparts/Kaken)Noer Kasanah, Mark T Hamann
Chemical Reviews|April 13, 2011
Chemistry and biology of kahalalidesJiangtao Gao, Mark T Hamann
Biochimica Et Biophysica Acta. General Subjects|August 29, 2017
Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacologyVedanjali Gogineni, Mark T Hamann
Advances in Cancer Research|July 28, 2019
Marine natural products in the discovery and development of potential pancreatic cancer therapeuticsXiaojuan Wang, Mark T Hamann
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Current Pharmaceutical Design|April 8, 2003
Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysisMark T Hamann
Current Pharmaceutical Design|March 10, 2007
The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural productsMark T Hamann
Current Opinion in Molecular Therapeutics|January 25, 2005
Technology evaluation: Kahalalide F, PharmaMarMark T Hamann
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistanceNoer Kasanah, Mark T Hamann
Life Sciences|October 21, 2005
Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseasesWaseem Gul, Mark T Hamann
Organic Letters|March 12, 2013
Atkamine: a new pyrroloiminoquinone scaffold from the cold water Aleutian Islands Latrunculia spongeYike Zou, Mark T Hamann
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
SPK-843 (Aparts/Kaken)Noer Kasanah, Mark T Hamann
Chemical Reviews|April 13, 2011
Chemistry and biology of kahalalidesJiangtao Gao, Mark T Hamann
Biochimica Et Biophysica Acta. General Subjects|August 29, 2017
Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacologyVedanjali Gogineni, Mark T Hamann
Advances in Cancer Research|July 28, 2019
Marine natural products in the discovery and development of potential pancreatic cancer therapeuticsXiaojuan Wang, Mark T Hamann
Pageof 17